Peter Sandercock

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Medicine, Pharmacology, Pharmacotherapy +10

Classification and natural history of clinically identifiable subtypes of cerebral infarction

John Bamford, Peter Sandercock, Martin Dennis et al. · The Lancet · 1991 · 3.3K citations

Medicine, Neurology, Neurosurgery +16

International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion

Andrew Molyneux, Richard Kerr, Ly‐Mee Yu et al. · The Lancet · 2005 · 2.9K citations

Medicine, Neurosurgery, Surgery +17

Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial

Ian Roberts, David Yates, Peter Sandercock et al. · The Lancet · 2004 · 1.1K citations

Medicine, Pharmacotherapy, Trauma Neurosurgery +10

Blood Pressure and Clinical Outcomes in the International Stroke Trial

Jo Leonardi‐Bee, Philip M. Bath, Stephen Phillips et al. · Stroke · 2002 · 989 citations · Full text

Medicine, Internal Medicine, Neurology +14